A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.
<h4>Objective</h4>To investigate the association between metabolic risk factors (individually and in combination) and risk of gallbladder cancer (GBC).<h4>Methods</h4>The metabolic syndrome and cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden with dat...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089368&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850189773199638528 |
|---|---|
| author | Wegene Borena Michael Edlinger Tone Bjørge Christel Häggström Björn Lindkvist Gabriele Nagel Anders Engeland Tanja Stocks Susanne Strohmaier Jonas Manjer Randi Selmer Steinar Tretli Hans Concin Goran Hallmans Håkan Jonsson Pär Stattin Hanno Ulmer |
| author_facet | Wegene Borena Michael Edlinger Tone Bjørge Christel Häggström Björn Lindkvist Gabriele Nagel Anders Engeland Tanja Stocks Susanne Strohmaier Jonas Manjer Randi Selmer Steinar Tretli Hans Concin Goran Hallmans Håkan Jonsson Pär Stattin Hanno Ulmer |
| author_sort | Wegene Borena |
| collection | DOAJ |
| description | <h4>Objective</h4>To investigate the association between metabolic risk factors (individually and in combination) and risk of gallbladder cancer (GBC).<h4>Methods</h4>The metabolic syndrome and cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden with data on 578,700 men and women. We used Cox proportional hazard regression models to calculate relative risks of GBC by body mass index (BMI), blood pressure, and plasma levels of glucose, cholesterol, and triglycerides as continuous standardised variables and their standardised sum of metabolic syndrome (MetS) z-score. The risk estimates were corrected for random error in measurements.<h4>Results</h4>During an average follow-up of 12.0 years (SD = 7.8), 184 primary gallbladder cancers were diagnosed. Relative risk of gallbladder cancer per unit increment of z-score adjusted for age, smoking status and BMI (except for BMI itself) and stratified by birth year, sex and sub-cohorts, was for BMI 1.31 (95% confidence interval 1.11, 1.57) and blood glucose 1.76 (1.10, 2.85). Further analysis showed that the effect of BMI on GBC risk is larger among women in the premenopausal age group (1.84 (1.23, 2.78)) compared to those in the postmenopausal age group (1.29 (0.93, 1.79)). For the other metabolic factors no significant association was found (mid blood pressure 0.96 (0.71, 1.31), cholesterol 0.84 (0.66, 1.06) and serum triglycerides 1.16 (0.82, 1.64)). The relative risk per one unit increment of the MetS z-score was 1.37 (1.07, 1.73).<h4>Conclusion</h4>This study showed that increasing BMI and impaired glucose metabolism pose a possible risk for gallbladder cancer. Beyond the individual factors, the results also showed that the metabolic syndrome as an entity presents a risk constellation for the occurrence of gallbladder cancer. |
| format | Article |
| id | doaj-art-bee9f66c8f514f9490a8a08e4fc2f875 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-bee9f66c8f514f9490a8a08e4fc2f8752025-08-20T02:15:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8936810.1371/journal.pone.0089368A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.Wegene BorenaMichael EdlingerTone BjørgeChristel HäggströmBjörn LindkvistGabriele NagelAnders EngelandTanja StocksSusanne StrohmaierJonas ManjerRandi SelmerSteinar TretliHans ConcinGoran HallmansHåkan JonssonPär StattinHanno Ulmer<h4>Objective</h4>To investigate the association between metabolic risk factors (individually and in combination) and risk of gallbladder cancer (GBC).<h4>Methods</h4>The metabolic syndrome and cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden with data on 578,700 men and women. We used Cox proportional hazard regression models to calculate relative risks of GBC by body mass index (BMI), blood pressure, and plasma levels of glucose, cholesterol, and triglycerides as continuous standardised variables and their standardised sum of metabolic syndrome (MetS) z-score. The risk estimates were corrected for random error in measurements.<h4>Results</h4>During an average follow-up of 12.0 years (SD = 7.8), 184 primary gallbladder cancers were diagnosed. Relative risk of gallbladder cancer per unit increment of z-score adjusted for age, smoking status and BMI (except for BMI itself) and stratified by birth year, sex and sub-cohorts, was for BMI 1.31 (95% confidence interval 1.11, 1.57) and blood glucose 1.76 (1.10, 2.85). Further analysis showed that the effect of BMI on GBC risk is larger among women in the premenopausal age group (1.84 (1.23, 2.78)) compared to those in the postmenopausal age group (1.29 (0.93, 1.79)). For the other metabolic factors no significant association was found (mid blood pressure 0.96 (0.71, 1.31), cholesterol 0.84 (0.66, 1.06) and serum triglycerides 1.16 (0.82, 1.64)). The relative risk per one unit increment of the MetS z-score was 1.37 (1.07, 1.73).<h4>Conclusion</h4>This study showed that increasing BMI and impaired glucose metabolism pose a possible risk for gallbladder cancer. Beyond the individual factors, the results also showed that the metabolic syndrome as an entity presents a risk constellation for the occurrence of gallbladder cancer.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089368&type=printable |
| spellingShingle | Wegene Borena Michael Edlinger Tone Bjørge Christel Häggström Björn Lindkvist Gabriele Nagel Anders Engeland Tanja Stocks Susanne Strohmaier Jonas Manjer Randi Selmer Steinar Tretli Hans Concin Goran Hallmans Håkan Jonsson Pär Stattin Hanno Ulmer A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS ONE |
| title | A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. |
| title_full | A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. |
| title_fullStr | A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. |
| title_full_unstemmed | A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. |
| title_short | A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. |
| title_sort | prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer me can collaborative study |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089368&type=printable |
| work_keys_str_mv | AT wegeneborena aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT michaeledlinger aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT tonebjørge aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT christelhaggstrom aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT bjornlindkvist aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT gabrielenagel aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT andersengeland aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT tanjastocks aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT susannestrohmaier aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT jonasmanjer aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT randiselmer aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT steinartretli aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT hansconcin aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT goranhallmans aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT hakanjonsson aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT parstattin aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT hannoulmer aprospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT wegeneborena prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT michaeledlinger prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT tonebjørge prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT christelhaggstrom prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT bjornlindkvist prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT gabrielenagel prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT andersengeland prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT tanjastocks prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT susannestrohmaier prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT jonasmanjer prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT randiselmer prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT steinartretli prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT hansconcin prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT goranhallmans prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT hakanjonsson prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT parstattin prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy AT hannoulmer prospectivestudyonmetabolicriskfactorsandgallbladdercancerinthemetabolicsyndromeandcancermecancollaborativestudy |